ArticleBlood2021

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy.

Nikolaos Ioannou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.